LIFE

Q: What is the price of aTyr Pharma (LIFE) today?

The current price of aTyr Pharma (LIFE) is $15.26. The stock began the year trading around $0.00 and is currently priced at $15.26. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does aTyr Pharma (LIFE) pay dividends?

aTyr Pharma (LIFE) did not pay dividends over the past year.

Q: Is aTyr Pharma (LIFE) a good investment?

aTyr Pharma (LIFE) is currently trading at $15.26 with a P/E ratio of -5.96. This represents a -191% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

aTyr Pharma Inc.

Price

$15.26

return (12m)

0.00%

p/e

-5.96

p/bv

1.75

DIVIDEND YIELD

0.00%

LIFE price

aTyr Pharma

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LIFE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-13.79%

3 months

42.88%

1 year

0.00%

2 years

910.60%

5 years

217.26%

10 years

-57.42%

Fundamentals LIFE

review the fundamentals of aTyr Pharma shares

P/E

-5.96

Sector: -3.91 Industry: -3.91

P/S (PSR)

1.94

Sector: -4.11 Industry: -4.11

P/BV

1.75

Sector: 1.95 Industry: 1.95

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-20.92%

Sector: -65.76% Industry: -65.76%

ROE

-29.36%

Sector: -65.99% Industry: -65.99%

ROIC

-196.27%

Sector: -2,915.77% Industry: -2,915.77%

NET MARGIN

-32.55%

Sector: -40.24% Industry: -40.24%

GROSS MARGIN

98.27%

Sector: 36.75% Industry: 36.75%

OPERATING MARGIN

-31.73%

Sector: -39.10% Industry: -39.10%

EV/EBITDA

-6.58

Sector: -4.01 Industry: -4.01

EV/EBIT

-6.34

Sector: -4.09 Industry: -4.09

PRICE-TO-ASSETS

1.25

Sector: 1.44 Industry: 1.44

BVPS

9.19

Sector: 1.85 Industry: 1.85

EPS

-2.70

Sector: -2.14 Industry: -2.14

EQUITY-TO-ASSETS RATIO

0.71

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.29

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

Fundamentals LIFE

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.15	6.78	25.92%	2.29%	$550.19 B	21.83%
PFE	19.15	1.59	8.29%	6.82%	$143.47 B	11.83%
ABBV	104.57	-57.49	-54.98%	3.14%	$380.13 B	5.79%
NVO	11.11	6.71	60.40%	3.92%	$210.69 B	37.15%
MRK	31.50	6.13	19.45%	2.92%	$281.49 B	13.59%
AZN	26.08	5.72	21.93%	1.83%	$270.97 B	17.19%
GILD	16.57	6.52	39.33%	2.59%	$152.71 B	30.99%
BMY	15.13	5.47	36.19%	4.63%	$110.05 B	15.01%
ZTS	12.57	10.27	81.75%	2.62%	$33.22 B	27.79%
REGN	14.34	2.02	14.08%	0.60%	$63.43 B	29.65%
HALO	23.19	36.83	158.82%	0.00%	$8.09 B	23.13%
AMGN	23.37	19.84	84.87%	2.90%	$182.30 B	20.96%
MCK	19.23	-109.80	-570.98%	0.42%	$91.58 B	1.18%
VRTX	26.44	5.92	22.41%	0.00%	$114.71 B	35.51%
HRMY	13.25	2.12	16.00%	0.00%	$1.93 B	16.20%
CAH	33.52	-19.50	-58.20%	0.92%	$52.12 B	0.62%
BIIB	21.06	1.55	7.36%	0.00%	$28.90 B	13.81%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LIFE Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT aTyr Pharma

aTyr Pharma Inc.

Average Investor10 user rating

4.0 (0 people)

United States

21 years

Founded: 2005

Time since IPO - - year

44

Employees

aTyr Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $772.80 million, with shareholders equity totaling $441.32 million.

The company employs approximately 44 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, aTyr Pharma Inc. reported $398.07 million in revenue, generating net income of $-129.58 million.

Key financial metrics include a P/E ratio of -5.96, a price-to-book (P/B) ratio of 1.75, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LIFE.

Market cap

$772.80 million

Net worth

$441.32 million

$441,320,000.00

Assets

$619.36 million

$619,360,000.00

Total Shares Outstanding

48.00 million

48,000,000

Average Daily Trading Volume

$535.10 Thousand

$535,103.46

Sector

Health Care

Industry

Biotechnology

LIFE

LIFE revenue and profits

Financial Results LIFE

DRAG THE FRAME TO SEE MORE DATA

LIFE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$763.91 6,51% (12M)

P/E

19.23

0.42%

ROE

-570.98%

P/BV

-109.80

CAH - Cardinal Health

$228.91 41,32% (12M)

P/E

33.52

0.92%

ROE

-58.20%

P/BV

-19.50

JNJ - Johnson & Johnson

$239.08 61,04% (12M)

P/E

26.15

2.29%

ROE

25.92%

P/BV

6.78

MRK - Merck & Co.

$119.60 55,38% (12M)

P/E

31.50

2.92%

ROE

19.45%

P/BV

6.13

AZN - AstraZeneca

$181.02 32,17% (12M)

P/E

26.08

1.83%

ROE

21.93%

P/BV

5.72

ABBV - AbbVie

$234.76 31,68% (12M)

P/E

104.57

3.14%

ROE

-54.98%

P/BV

-57.49

NVO - Novo Nordisk

$47.42 --26,19% (12M)

P/E

11.11

3.92%

ROE

60.40%

P/BV

6.71

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$763.91 6,51% (12 M)

P/L

19.23

0.42%

ROE

-570.98%

P/VP

-109.80

CAH - Cardinal Health

$228.91 41,32% (12 M)

P/L

33.52

0.92%

ROE

-58.20%

P/VP

-19.50

JNJ - Johnson & Johnson

$239.08 61,04% (12 M)

P/L

26.15

2.29%

ROE

25.92%

P/VP

6.78

MRK - Merck & Co.

$119.60 55,38% (12 M)

P/L

31.50

2.92%

ROE

19.45%

P/VP

6.13

AZN - AstraZeneca

$181.02 32,17% (12 M)

P/L

26.08

1.83%

ROE

21.93%

P/VP

5.72

ABBV - AbbVie

$234.76 31,68% (12 M)

P/L

104.57

3.14%

ROE

-54.98%

P/VP

-57.49

NVO - Novo Nordisk

$47.42 --26,19% (12 M)

P/L

11.11

3.92%

ROE

60.40%

P/VP

6.71

Frequently Asked Questions

What is the price of aTyr Pharma (LIFE) today?

The current price of aTyr Pharma (LIFE) is $15.26. The stock began the year trading around $0.00 and is currently priced at $15.26. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does aTyr Pharma (LIFE) pay dividends?

aTyr Pharma (LIFE) did not pay dividends over the past year.

Is aTyr Pharma (LIFE) a good investment?

aTyr Pharma (LIFE) is currently trading at $15.26 with a P/E ratio of -5.96. This represents a -191% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy aTyr Pharma (LIFE) stock?

You can buy aTyr Pharma (LIFE) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol LIFE and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of aTyr Pharma (LIFE) yield today?

Over the past month, aTyr Pharma (LIFE) has returned -13.79% — 0.00% over the past year, and 217.26% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of aTyr Pharma (LIFE) today at the current price of $15.26 your total investment would be $1,526.00.

Based on historical performance, the investment would have grown to approximately:

$1,526.00 after 1 year
$4,841.39 after 5 years
$649.77 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LIFE

aTyr Pharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LIFE

review the fundamentals of aTyr Pharma shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT aTyr Pharma

aTyr Pharma Inc.

United States

21 years

44

Financial Results LIFE

LIFE cash flow

Asset, Revenue and Profit Growth - LIFE

LIFE balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions